Status:
RECRUITING
Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study
Lead Sponsor:
Radboud University Medical Center
Conditions:
Scabies
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
In this cross-sectional diagnostic study, healthy adults aged 18 and older with suspected, clinical, or confirmed scabies will be recruited. The objective is to determine if the sensitivity of self-co...
Detailed Description
Scabies infestations have significantly increased globally in the last 10-20 years, including a threefold rise in the Netherlands over the past decade. Diagnosing scabies is challenging due to varied ...
Eligibility Criteria
Inclusion
- 18 years or older
- Have either suspected scabies, clinical scabies or confirmed scabies (see table 1)
- Providing informed consent (IC)
Exclusion
- Individuals not speaking or understanding the Dutch or English language.
- Individuals who have been diagnosed with scabies in the last six weeks and had started treatment.
- Individuals who have used ivermectin for other diagnoses than scabies in the last six weeks.
- Individuals younger than 18 years.
- Individuals with immunosuppressive conditions (see appendix A).
- Any other condition, finding or situation which, in the opinion of the investigator, may significantly increase the risk to the individual because of participation in the study, affect the ability of the individual to participate in the study or impair interpretation of the study data.
Key Trial Info
Start Date :
August 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06546579
Start Date
August 21 2024
End Date
June 1 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525GA